midazolam
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
14 FDA-registered drug labelers
B. Braun Medical Inc.
Cambrex Profarmaco Milano Srl
COHANCE LIFESCIENCES LIMITED
F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
Fagron Inc
LETCO MEDICAL, LLC
Pharma Source Direct, Inc.
Professional Compounding Centers of America dba PCCA
Rafa Laboratories, Ltd.
Spectrum Laboratory Products, Inc.
Supriya Lifescience Limited
UCB, Inc.
Wavelength Enterprises LTD
WG Critical Care, LLC.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Midazolam in Sodium Chloride
- •Midazolam IN 0.8% Sodium Chloride
- •Nayzilam
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Midazolam Hydrochloride Injection
04/02/2020Unavailable
current
Midazolam Hydrochloride Injection
04/02/2020Available
current
Midazolam Hydrochloride Injection
04/02/2020Limited Availability
Chemical Identity
CAS59467-70-8
PubChem CID4192
DTXSIDDTXSID5023320
FormulaC18H13ClFN3
Mol. Weight325.8 g/mol
SMILESCC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
Data Sources
41922026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/midazolam/cids/JSON
Archive: data/sources/pubchem_name/midazolam.json
CAS 59467-70-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 59467-70-82026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json